| The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail? DM Hartung, DN Bourdette, SM Ahmed, RH Whitham Neurology 84 (21), 2185-2192, 2015 | 337 | 2015 |
| Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs EH Morrato, B Druss, DM Hartung, RJ Valuck, R Allen, E Campagna, ... Archives of general psychiatry 67 (1), 17-24, 2010 | 277 | 2010 |
| Reporting discrepancies between the ClinicalTrials. gov results database and peer-reviewed publications DM Hartung, DA Zarin, JM Guise, M McDonagh, R Paynter, M Helfand Annals of internal medicine 160 (7), 477-483, 2014 | 239 | 2014 |
| Metabolic screening in children receiving antipsychotic drug treatment EH Morrato, GE Nicol, D Maahs, BG Druss, DM Hartung, RJ Valuck, ... Archives of pediatrics & adolescent medicine 164 (4), 344-351, 2010 | 179 | 2010 |
| Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review R Chou, D Hartung, B Rahman, N Wasson, EB Cottrell, R Fu Annals of internal medicine 158 (2), 114-123, 2013 | 158 | 2013 |
| Opioid treatments for chronic pain R Chou, D Hartung, J Turner, I Blazina, B Chan, X Levander, ... | 137 | 2020 |
| The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs B Bebo, I Cintina, N LaRocca, L Ritter, B Talente, D Hartung, ... Neurology 98 (18), e1810-e1817, 2022 | 112 | 2022 |
| Economics and cost-effectiveness of multiple sclerosis therapies in the USA DM Hartung Neurotherapeutics 14 (4), 1018-1026, 2017 | 108 | 2017 |
| Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders P Bach, D Hartung Addiction science & clinical practice 14 (1), 30, 2019 | 102 | 2019 |
| Rates of adverse events of long-acting opioids in a state Medicaid program DM Hartung, L Middleton, DG Haxby, M Koder, KL Ketchum, R Chou Annals of Pharmacotherapy 41 (6), 921-928, 2007 | 97 | 2007 |
| Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population DM Hartung, MJ Carlson, DF Kraemer, DG Haxby, KL Ketchum, ... Medical care 46 (6), 565-572, 2008 | 88 | 2008 |
| Overview of clinical research design DM Hartung, D Touchette American Journal of Health-System Pharmacy 66 (4), 398-408, 2009 | 87 | 2009 |
| Clinical implications of an accurate problem list on heart failure treatment DM Hartung, J Hunt, J Siemienczuk, H Miller, DR Touchette Journal of general internal medicine 20, 143-147, 2005 | 87 | 2005 |
| Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies DM Hartung, D McCarty, R Fu, K Wiest, M Chalk, DR Gastfriend Journal of substance abuse treatment 47 (2), 113-121, 2014 | 78 | 2014 |
| Pharmacy-related buprenorphine access barriers: an audit of pharmacies in counties with a high opioid overdose burden NJ Kazerouni, AN Irwin, XA Levander, J Geddes, K Johnston, ... Drug and alcohol dependence 224, 108729, 2021 | 67 | 2021 |
| The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis AS Meeker, MC Herink, DG Haxby, DM Hartung Systematic reviews 4, 1-16, 2015 | 67 | 2015 |
| Pharmacists’ role in opioid safety: a focus group investigation DM Hartung, J Hall, SN Haverly, D Cameron, L Alley, C Hildebran, ... Pain Medicine 19 (9), 1799-1806, 2018 | 64 | 2018 |
| Association of pharmacist prescription of hormonal contraception with unintended pregnancies and Medicaid costs MI Rodriguez, A Hersh, LB Anderson, DM Hartung, AB Edelman Obstetrics & Gynecology 133 (6), 1238-1246, 2019 | 55 | 2019 |
| Industry payments to physician specialists who prescribe repository corticotropin DM Hartung, K Johnston, DM Cohen, T Nguyen, A Deodhar, ... JAMA network open 1 (2), e180482-e180482, 2018 | 52 | 2018 |
| Risk of Hospitalization for Heart Failure Associated with Thiazolidinedione Therapy: A Medicaid Claims–Based Case‐Control Study DM Hartung, DR Touchette, NC Bultemeier, DG Haxby Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (10 …, 2005 | 52 | 2005 |
